Senores Pharmaceuticals Ltd. Senores Pharmaceuticals Limited is an India-based pharmaceutical company. The Company manufactures products of international quality to cater to the increasing new age demands of the global healthcare industry. The Company's products include Amphetamine Sulfate Tablets USP, 5 mg and 10 mg; Hydroxychloroquine Sulfate Tablets USP, 200 mg; Ketoconazole Tablets USP, 200 mg; Chlorzoxazone Tablets USP, 250 mg; 5Chlorzoxazone Tablets USP, 500 mg; Ketorolac Tromethamine Tablets USP, 10 mg; Diclofenac Potassium Tablets USP, 25 mg; Diclofenac Potassium Tablets USP, 50 mg, and others. It supplies affordable APIs to generic formulations manufacturers. Its product API include Anastrozole, Aripiprazole, Benfotiamine, Clomiphene Citrate, Desloratadine, Desvenlafaxine Succinate, Fluoxetine Hydrochloride, and others. Its domestic portfolio includes Azithromycin for Injection; Meropenem Injection; Ferric Carboxymaltose Injection; Meropenem and Sulbactam for Injection, and others.
Senores Pharmaceutic FAQs
How to Buy Senores Pharmaceutic Share?
To purchase Senores Pharmaceutic shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Senores Pharmaceutic (ticker symbol: SENORES) on the trading platform provided by your broker and purchase the shares.
What's Senores Pharmaceutic share price today?
The stock price of Senores Pharmaceutic as of 01 Jun 2025 is ₹518.45
What is the Market Cap of Senores Pharmaceutic?
Market capitalisation represents the total market value of a company's outstanding shares. As of 01 Jun 2025, Senores Pharmaceutic (ticker symbol: SENORES) has a market capitalisation of approximately ₹23,90,00,00,000.00
What is the PE and PB ratio of Senores Pharmaceutic?
Senores Pharmaceutic Ltd's price-to-book ratio as of 01 Jun 2025 is 7.74, reflecting the market's valuation compared to its asset value. As of 01 Jun 2025, the trailing twelve months P/E (price-to-earnings) ratio is 50.29, indicating the market values the company at around ₹50.29 for every ₹1 of earnings
What is the 52 Week High and Low of Senores Pharmaceutic Share?
Senores Pharmaceutic Ltd (SENORES) hit its 52-week high at ₹665.00, and its 52-week low at ₹435.25.